Equities

Bayer Cropscience Ltd

BAYERCROP:NSI

Bayer Cropscience Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)5,986.05
  • Today's Change-113.95 / -1.87%
  • Shares traded22.23k
  • 1 Year change+8.94%
  • Beta0.6085
Data delayed at least 15 minutes, as of Nov 14 2024 04:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments12,1079,0198,194
Total Receivables, Net10,55110,84111,240
Total Inventory15,85818,32415,469
Prepaid expenses6867113
Other current assets, total471713739
Total current assets39,05538,96435,755
Property, plant & equipment, net3,8264,3134,504
Goodwill, net------
Intangibles, net1,2541,147893
Long term investments251256261
Note receivable - long term30912098
Other long term assets72214230
Total assets45,97146,78643,529
LIABILITIES
Accounts payable6,0518,7328,198
Accrued expenses8.005.00--
Notes payable/short-term debt000
Current portion long-term debt/capital leases261371346
Other current liabilities, total9,6548,6678,049
Total current liabilities15,97417,77516,593
Total long term debt210364518
Total debt471735864
Deferred income tax403.00--
Minority interest------
Other liabilities, total1,2531,5231,175
Total liabilities17,47719,66518,286
SHAREHOLDERS EQUITY
Common stock449449449
Additional paid-in capital1,3941,3941,394
Retained earnings (accumulated deficit)26,65125,27823,400
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity28,49427,12125,243
Total liabilities & shareholders' equity45,97146,78643,529
Total common shares outstanding454545
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.